Clinical challenges in wound management workshop
Are you interested in improving outcomes in wound management in people with cancer? Cancer Symptom Trials (CST) is hosting a Clinical challenges in wound management workshop facilitated by Elizabeth Harry.
Background: malignant wounds
It is estimated that malignant wounds present in 5-14% of advanced cancer patients , often occurring in the last 6 months of life and most commonly associated with breast or head and neck cancers. Malignant wounds are caused by direct infiltration of the skin, tissues, mucosa, blood or lymph vessels by a tumour or metastatic deposit. Patients find these wounds extremely distressing and uncomfortable as they can be painful, become infected, produce high levels of exudate, cause bleeding and be malodourous. In particular, wound malodour is an overwhelming concern for the patient, their family, and carers, at times preventing people being in the same room as the patient.
The physiological, psychological and sociological consequences of living with a malodorous wound have a dramatic impact on the comfort, the overall pain experience and the quality of life for individuals and those around them, in the face of terminal disease. The holistic management of these wounds is challenging as there is no robust evidence for which of the current treatment options are the most effective at improving quality of life or managing symptoms, hence warranting further research. (Source: Professor Elizabeth Harry, UTS, 2020; unpublished)
Cancer Symptom Trials (CST) is hosting a Clinical challenges in wound management workshop. The workshop will bring together clinicians, researchers and consumers to consider new study ideas that will generate evidence to enhance clinical management and decision making around malignant wounds.
Present your study idea
If this is an area of interest to you, we encourage you and your colleagues to submit new study ideas for presentation at the workshop.
To present your malignant wound management study idea, please complete the PowerPoint template linked below and submit it by email to CST@uts.edu.au.
Study idea template instructions:
- Malignant wound management study ideas must be submitted on the linked PowerPoint template and must not exceed the four slides in the template – we only want preliminary information at this point.
- Submissions are due by COB Thursday 5 November 2020.
- Submissions must be emailed to CST@uts.edu.au.
- CST will review all submissions and advise those who have been chosen to present at the workshop by Thursday 12 November.
- If your idea is chosen to present and you are unable to attend, it would be appreciated if you could nominate a proxy to attend and present on your behalf.
- Presentations at the workshop will not exceed 20 minutes to allow time for multiple presentations.
Profile of facilitator and presenter
Liz Harry is a Professor of Biology at the ithree institute (infection, immunology and innovation) at UTS. She leads the Cell Division and Antimicrobials group in ithree. She has pioneered the use of advanced imaging for bacteria to understand their biology. Liz values the translation of research for public good and she has worked with industry in antibiotic discovery and in the use of natural products as effective therapeutics for infectious disease.
Liz has been awarded a series of research fellowships: Fogarty Fellowship (NIH, USA), ARC Postdoctoral Fellowship, ARC QEII Fellowship. She undertook post-doctoral research at Harvard University and the University of Sydney. She moved to UTS in 2005. In recognition of her distinguished research contributions she was awarded the 2008 Frank Fenner Award (Australian Society for Microbiology) and received the 2002 Australian Eureka Prize for Scientific Research. In 2016 she was included in the SBS list of six impressive Aussie women scientists. Liz is passionate about effective and successful academic leadership, and in developing a team culture that allows each person to be ‘dressed for success’.